The inhibition of plasminogen activation and attenuation of PAI-1 mediated plasminogen activator inactivation by the Kunitz inhibitor

被引：0
|
作者：
Liu, JN [1 ]
Sun, ZY [1 ]
Tang, W [1 ]
Gurewich, V [1 ]
机构：
[1] HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,INST PREVENT CARDIOVASC DIS,VASC RES LAB,BOSTON,MA 02215
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1499 / 1499
页数：1
相关论文
共 50 条
  • [31] Do plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator PAI-1 complexes (tPA-PAI-1) Predict complications in type 1 diabetes (TID)?
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Orchard, TJ
    DIABETES, 2001, 50 : A209 - A209
  • [32] VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: involvement of the VLDL receptor
    Nilsson, L
    Gåfvels, M
    Musakka, L
    Ensler, K
    Strickland, DK
    Angelin, B
    Hamsten, A
    Eriksson, P
    JOURNAL OF LIPID RESEARCH, 1999, 40 (05) : 913 - 919
  • [33] Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1)
    Schneider, DJ
    Hayes, M
    Wadsworth, M
    Taatjes, H
    Rincón, M
    Taatjes, DJ
    Sobel, BE
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (08) : 1091 - 1099
  • [34] VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression:: Involvement of the VLDL receptor
    Nilsson, L
    Gåfvels, M
    Musakka, L
    Ensler, K
    Strickland, DK
    Angelin, B
    Hamsten, A
    Eriksson, P
    ATHEROSCLEROSIS, 1999, 144 : 112 - 113
  • [35] INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AND TISSUE PLASMINOGEN-ACTIVATOR (T-PA) ON FIBRIN
    WAGNER, OF
    HOHMANN, C
    VEERMAN, H
    DEVRIES, C
    VOORN, P
    LAMBERS, H
    KLEINGEBBINK, R
    EHRLICH, HJ
    PANNEKOEK, H
    BLUT, 1988, 57 (04): : 184 - 184
  • [36] Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome
    Kulwas, Arleta
    Lisewska, Beata
    Jundzill, Wieslaw
    Ruszkowska, Barbara
    Drewniak, Wanda
    Ruprecht, Zofia
    Gadomska, Grazyna
    Rosc, Danuta
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (01): : 87 - 91
  • [37] REVERSIBLE INTERACTIONS BETWEEN PLASMINOGEN ACTIVATORS (PAS) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    KANEKO, M
    SAKURAMA, T
    MURAKAMI, T
    MATSUDA, M
    SAKATA, Y
    MIMURO, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1326 - 1326
  • [38] Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study
    Bosnyak, Z
    Forrest, KYZ
    Maser, RE
    Becker, D
    Orchard, TJ
    DIABETIC MEDICINE, 2003, 20 (02) : 147 - 151
  • [39] Plasminogen activator inhibitor-1 (PAI-1) is an endogenous inhibitor of retinal neovascularization.
    Ando, A
    Mori, K
    Yamada, H
    Yamada, E
    Campochiaro, PA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S537 - S537
  • [40] Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1)
    Gopal, Santhosh
    Garibaldi, Silvia
    Goglia, Lorenzo
    Polak, Kinga
    Palla, Giulia
    Spina, Stefania
    Genazzani, Andrea R.
    Genazzani, Alessandro D.
    Simoncini, Tommaso
    MOLECULAR HUMAN REPRODUCTION, 2012, 18 (08) : 410 - 416
12345